Guilin Pharmaceutical Co., Ltd
FDA inspection history in Guilin, China, 2015
- 1
- Form 483
Every document, by year
- Form 483
2015: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2015One Form 483, at Guilin, China.
Cited most
Across all Guilin Pharmaceutical Co. observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
The complete Guilin Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Guilin, China
One Form 483 · 2015 · 1 observation
Latest: Form 483, Mar 13, 2015 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2015-03-13 | 483 Form 483 | Guilin, China | 1 | $99 |
Investigators on these documents
FEI number 3002807125 · most recent document Mar 13, 2015
About Guilin Pharmaceutical Co., Ltd
How many FDA Form 483s has Guilin Pharmaceutical Co., Ltd received?
FDA Intel has 1 Form 483 on file for Guilin Pharmaceutical Co., Ltd; the most recent is dated Mar 13, 2015.
When was Guilin Pharmaceutical Co., Ltd last inspected by FDA?
The most recent FDA inspection document on file for Guilin Pharmaceutical Co., Ltd is a Form 483 dated Mar 13, 2015, for the site in Guilin, China.
What did FDA cite at Guilin Pharmaceutical Co., Ltd?
The regulations cited most in the observations on file for Guilin Pharmaceutical Co., Ltd are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.192 (Production record review), 1 time.